New $46M grant allows the University of Oxford and Boston Children’s Hospital to lead Genetic Medicines Hub within ARIA ecosystem

The University of Oxford and Boston Children’s Hospital, with collaboration from The Jackson Laboratory and N=1 Collaborative, have been selected to establish a new Genetic Medicines Hub, one of six…

Continue ReadingNew $46M grant allows the University of Oxford and Boston Children’s Hospital to lead Genetic Medicines Hub within ARIA ecosystem

Lab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

Lab Thread Ltd, a UK-based life science software company, today announced the launch of a new Model Context Protocol (MCP) server that lets scientists connect their own AI assistants directly…

Continue ReadingLab Thread launches new AI tools and strengthens platform with universal AI assistant compatibility

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated…

Continue ReadingQureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at…

Continue ReadingCrystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

BioUK Ltd., the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced that it has acquired certain key assets of SEHTA (Science and Engineering Health Technologies…

Continue ReadingBioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK